SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-151231
Filing Date
2021-12-17
Accepted
2021-12-17 17:15:28
Documents
12
Period of Report
2021-12-17
Items
Item 1.02: Termination of a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2135808d1_8k.htm   iXBRL 8-K 25828
  Complete submission text file 0001104659-21-151231.txt   197524

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA alt-20211217.xsd EX-101.SCH 3025
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE alt-20211217_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alt-20211217_pre.xml EX-101.PRE 22360
5 EXTRACTED XBRL INSTANCE DOCUMENT tm2135808d1_8k_htm.xml XML 3597
Mailing Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878
Business Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Filer) CIK: 0001326190 (see all company filings)

IRS No.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32587 | Film No.: 211502599
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences